Proceedings of the IASLC international workshop on advances in pulmonary neuroendocrine tumors 2007

Eric Lim, Peter Goldstraw, Andrew G. Nicholson, William D. Travis, James R. Jett, Piero Ferolla, Jamshed Bomanji, Valerie W. Rusch, Hisao Asamura, Britt Skogseid, Eric Baudin, Martyn Caplin, Dik Kwekkeboom, Elisabeth Brambilla, John Crowley

Research output: Contribution to journalArticlepeer-review

75 Citations (Scopus)


The International Association for the Study of Lung Cancer, (IASLC) International Congress on Advances in Pulmonary Neuroendocrine Tumors was a two-day meeting held at the Royal Brompton Hospital in London, United Kingdom on the thirteenth and forteenth of December 2007. The meeting was led by 14 member international faculty-in the disciplines of pathology, surgery, medicine, oncology, endocrinology, nuclear medicine, diagnostic imaging, and biostatistics. The aims were twofold, as an educational meeting, and to develop the IASLC International Pulmonary Neuroendocrine Tumors Registry. The meeting highlighted the difference in presentation of the tumors, management options for early and advanced stage disease including the use of novel agents and approaches. The need, process, and approach to an International Registry of Pulmonary Neuroendocrine Tumors were emphasized. International collaboration to develop a retrospective registry, prospective data collection, virtual tissue bank, and collaborative clinical trials were universally agreed as the best way to advance our understanding and treatment of these rare tumors.

Original languageEnglish
Pages (from-to)1194-1201
Number of pages8
JournalJournal of Thoracic Oncology
Issue number10
Publication statusPublished - 2008 Oct
Externally publishedYes


  • Atypical carcinoid
  • Carcinoma
  • Large cell neuroendocrine
  • Neuroendocrine tumours
  • Typical carcinoid

ASJC Scopus subject areas

  • Oncology
  • Pulmonary and Respiratory Medicine


Dive into the research topics of 'Proceedings of the IASLC international workshop on advances in pulmonary neuroendocrine tumors 2007'. Together they form a unique fingerprint.

Cite this